Three AI Giants Are Propping Up the Entire S&P 500 — Should Investors Worry?
Three AI stocks—Nvidia, Alphabet, and Micron—are driving over 40% of S&P 500 earnings growth, creating record concentration levels...
BitMine (BMNR) Stock Plunges 33% Despite Aggressive Ethereum Accumulation Strate...
BitMine (BMNR) holds 5.42M ETH valued at $10.8B despite a 33% stock drop. The company stakes 87% via MAVAN and targets 5% of Ether...
Zscaler (ZS) Stock Surges 10% on Guggenheim’s Bullish Upgrade
Zscaler (ZS) stock rallies 10% after Guggenheim upgrades to Buy with $214 target, calling it undervalued following earnings-driven...
Motorola Solutions (MSI) Stock Climbs on $1.5B Counter-Drone Acquisition
Motorola Solutions (MSI) stock jumped 2.75% after announcing a $1.5B acquisition of counter-drone technology firm D-Fend Solutions...
Palo Alto Networks (PANW) Q3 Earnings Preview: Analysts Forecast 28% Revenue Sur...
Palo Alto Networks (PANW) reports Q3 FY26 earnings June 2. Wall Street forecasts $2.94B revenue, up 28% YoY. Stock up 52.4% YTD ah...
Apple (AAPL) Stock Gains Momentum as Analysts Boost Targets Before WWDC Siri Unv...
Apple (AAPL) stock nears $315 as analysts upgrade targets before WWDC. Citi holds Buy at $315, Evercore raises to $365 on Siri AI...
IREN (IREN) Stock Dips as Subsidiary Lands $3.6B Financing for Microsoft AI Infr...
IREN stock slipped 2.31% as subsidiary IE US Hardware 3 LLC closed $3.6B financing to build GPU infrastructure for Microsoft data...
Broadcom (AVGO) Stock: What to Expect From Q2 Earnings Report on June 3
Broadcom (AVGO) reports Q2 earnings June 3. Analysts expect $22.12B revenue, $2.40 EPS. Options signal 10.65% post-earnings move....
NIO, XPeng, and Li Auto Stocks Rally Following May Delivery Reports
NIO stock rose 6.7% after reporting 62% YoY delivery growth in May. XPeng and Li Auto also released figures as Chinese EV stocks r...
Revolution Medicines (RVMD) Stock Soars 20% on Breakthrough Pancreatic Cancer Tr...
Revolution Medicines (RVMD) stock jumped 20% after daraxonrasib doubled pancreatic cancer survival to 13.2 months in Phase 3 trial...